Course Outline
Click on the links below to preview selected pages from this course.
- Coagulopathies
- Hemophilia
- Hemophilia
- Hemophilia A
- Factor Activity Assays
- Lab Interference
- Hemophilia B
- Which is true of a patient who has a prolonged aPTT and a factor VIII activity assay of <5%?
- Emicizumab is relevant to the lab for which of the following reasons?
- Disseminated Intravascular Coagulation
- Hypercoagulable Conditions
- Von Willebrand's Disease
- Lupus Anticoagulant
- Lupus Anticoagulant
- APS versus LAC
- Testing for LAC
- A dRVVT that corrects with normal donor plasma suggests:
- True or False: Antiphospholipid syndrome is a hypercoagulable state caused by the presence of antibodies against phospholipids or phospholipid-binding...
- References
Additional Information
Level of Instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical
laboratory technicians, laboratory supervisors, and laboratory managers. This
course is also appropriate for MLS and MLT students and pathology residents.
Author Information: Kevin F. Foley, PhD, MLS(ASCP)SC, DABCC, is the director of clinical pathology for the Kaiser Permanente Northwest region. He also teaches clinical chemistry at Oregon Health Sciences University. Dr. Foley earned his PhD in clinical pharmacology and toxicology at the East Carolina School of Medicine in North Carolina. He received a PhD in clinical pharmacology and toxicology from Brody School of Medicine, Greenville, NC. He has been working in laboratory medicine for over 15 years, starting his career as a medical laboratory scientist.
The author has no
conflict of interest to disclose.
Reviewer Information: Laurie Bjerklie, MA, MLS(ASCP)CM, is
a Lead Education Developer. She earned a B.S. in Medical Laboratory Science
from the University of North Dakota and an M.A. in Curriculum and Instruction
from Saint Xavier University. She has over 20 years of experience in higher
education and has held program director and faculty positions in both MLT and
MLS programs.
